155 related articles for article (PubMed ID: 8607129)
1. Fatal cerebral venous sinus thrombosis associated with the factor V Leiden mutation and the use of oral contraceptives.
Bridey F; Wolff M; Laissy JP; Morin V; Lefebvre M; de Prost D
Thromb Haemost; 1995 Nov; 74(5):1382. PubMed ID: 8607129
[No Abstract] [Full Text] [Related]
2. Venous thrombosis--the interaction of genes and environment.
Bertina RM; Rosendaal FR
N Engl J Med; 1998 Jun; 338(25):1840-1. PubMed ID: 9632453
[No Abstract] [Full Text] [Related]
3. Selective screening for the Factor V Leiden mutation: is it advisable prior to the prescription of oral contraceptives?
Schambeck CM; Schwender S; Haubitz I; Geisen UE; Grossmann RE; Keller F
Thromb Haemost; 1997 Dec; 78(6):1480-3. PubMed ID: 9423798
[TBL] [Abstract][Full Text] [Related]
4. A 21-year-old white woman diagnosed with cerebral venous sinus thrombosis related to oral contraceptive and Factor V Leiden.
Wharton HC
Adv Emerg Nurs J; 2012; 34(1):10-5. PubMed ID: 22313896
[TBL] [Abstract][Full Text] [Related]
5. Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptives.
Aznar J; Vayá A; Estellés A; Mira Y; Seguí R; Villa P; Ferrando F; Falcó C; Corella D; España F
Haematologica; 2000 Dec; 85(12):1271-6. PubMed ID: 11114134
[TBL] [Abstract][Full Text] [Related]
6. Factor V Leiden and contraception.
Ament L
J Midwifery Womens Health; 2004; 49(1):51-2. PubMed ID: 14710141
[TBL] [Abstract][Full Text] [Related]
7. Factor V gene mutation is a risk factor for cerebral venous thrombosis.
Martinelli I; Landi G; Merati G; Cella R; Tosetto A; Mannucci PM
Thromb Haemost; 1996 Mar; 75(3):393-4. PubMed ID: 8701395
[TBL] [Abstract][Full Text] [Related]
8. Factor V Leiden mutation in cerebral venous thrombosis.
Zuber M; Toulon P; Marnet L; Mas JL
Stroke; 1996 Oct; 27(10):1721-3. PubMed ID: 8841317
[TBL] [Abstract][Full Text] [Related]
9. [Perioperative management of a patient with factor V Leiden mutation].
Kotaka M; Kohchi A
Masui; 2003 Apr; 52(4):409-11. PubMed ID: 12728494
[TBL] [Abstract][Full Text] [Related]
10. Oral contraceptive users and screening of factor V Leiden.
Aznar J; Gilabert J
Thromb Haemost; 1999 May; 81(5):845-6. PubMed ID: 10365763
[No Abstract] [Full Text] [Related]
11. Increased rate of factor V Leiden mutation in patients with cerebral venous thrombosis.
Weih M; Vetter B; Ziemer S; Mehraein S; Valdueza JM; Koscielny J; Kulozik AE; Einhäupl KM
J Neurol; 1998 Mar; 245(3):149-52. PubMed ID: 9553844
[TBL] [Abstract][Full Text] [Related]
12. Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism.
Emmerich J; Rosendaal FR; Cattaneo M; Margaglione M; De Stefano V; Cumming T; Arruda V; Hillarp A; Reny JL
Thromb Haemost; 2001 Sep; 86(3):809-16. PubMed ID: 11583312
[TBL] [Abstract][Full Text] [Related]
13. Cerebral sinus thrombosis in a child with active ulcerative colitis and factor V Leiden.
Robison NJ; Dawlabani N; Lastra CR; Dhall G
Pediatr Blood Cancer; 2009 Jul; 52(7):867-9. PubMed ID: 19260108
[TBL] [Abstract][Full Text] [Related]
14. Oral contraceptives and screening for factor V Leiden.
Rosendaal FR
Thromb Haemost; 1996 Mar; 75(3):524-5. PubMed ID: 8701424
[No Abstract] [Full Text] [Related]
15. Effects of second and third generation oral contraceptives and their respective progestagens on the coagulation system in the absence or presence of the factor V Leiden mutation.
Kemmeren JM; Algra A; Meijers JC; Bouma BN; Grobbee DE
Thromb Haemost; 2002 Feb; 87(2):199-205. PubMed ID: 11859850
[TBL] [Abstract][Full Text] [Related]
16. [Factor V leiden and venous thromboembolism in a woman taking second generation oral contraceptives: a case report].
Undas A; Sanak M; Jankowski M; Undas R; Musiał J; Szczeklik A
Ginekol Pol; 1999 Feb; 70(2):93-7. PubMed ID: 10349814
[TBL] [Abstract][Full Text] [Related]
17. Concomitant heterozygous factor V Leiden mutation and homozygous prothrombin gene variant (G20210A) in patient with cerebral venous thrombosis.
Kurkowska-Jastrzebska I; Wicha W; Dowzenko A; Vertun-Baranowska B; Pytlewski A; Bogusławska R; Członkowska A
Med Sci Monit; 2003 May; 9(5):CS41-5. PubMed ID: 12761462
[TBL] [Abstract][Full Text] [Related]
18. Activated protein C resistance--a major risk factor for thrombosis.
Rosén SB; Sturk A
Eur J Clin Chem Clin Biochem; 1997 Jul; 35(7):501-16. PubMed ID: 9263726
[TBL] [Abstract][Full Text] [Related]
19. Consequences of thrombophilia screening for life quality in women before prescription of oral contraceptives and family members of VTE patients.
Eichinger S
Hamostaseologie; 2009 Jan; 29(1):110-1. PubMed ID: 19151859
[TBL] [Abstract][Full Text] [Related]
20. Thrombophilic mechanisms of OCs.
Comp PC
Int J Fertil Womens Med; 1997; Suppl 1():170-6. PubMed ID: 9168376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
